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Schizophrenia and Genomics
Tiffini Lasch, BSN, RN

Introduction
•

•

•

•

Patients with Schizophrenia (SZ)
struggle to determine reality vs.
non-reality. This
neurodevelopmental disorder is
not short-lived. Instead, SZ
requires life-time treatment.
Factors that impact SZ include
genetics, environment, and brain
disruptions (Mental Health
Information, n.d.). SZ is usually
discovered between the ages of 16
and 30. Most people do not
develop SZ after the age of 45.
Currently, a cure is not available
(Schizophrenia, n.d.).

Genomics is one of the future paths
to better medicine. The purpose of
this article is to understand how
genetic studies can lead to
improved treatment of SZ.

This topic was chosen to bring
awareness to what genomics can
do for those who have SZ and
acknowledge the need for more
studies to be completed. There
have been astonishing
advancement in gene therapy.
Gene therapy provides a cure for
certain cancers (Roth, 2019).
However, there has been a lack of
studies for analyzing rare noncoding variants for SZ (Takata,
2019). The mental health charity
showed that the United Kingdom
spent 5.5 % of its budget on
mental illness and 19.6% on
cancer, even though mental health
is a more significant burden (Kong
et al., 2017).

The genome-wide association
studies have found a genic
correlation between mental
disorders, polygenic heritability,
and other brain disorders. There
are over 150 genome-wide hits for
SZ, but there is a lack of
transitioning this knowledge to
public mental health. The lack of
transition into public mental
health is due to a lack of education
for clinicians. This ongoing
insufficient movement is why it is
important to start discussing and
educating. There is an urgent need
to keep working on discoveries.
(Merikngas & Merikangas, 2019).
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Signs and Symptoms
•
•
•
•
•
•
•
•
•
•
•
•
•

•
•
•
•

Hallucinations auditory and visual
Delusional
Paranoia
Nonsensical speech
Withdrawn
Cognitive issue effecting thought
process
Emotionless (Schizophrenia, n.d.)
Lack of motivation
Lack of planning
Disorganized thoughts
Lack of pleasure
Abnormal movements
Impaired memory and
concentration (Patient & Families:
Schizophrenia, n.d.)

Complications

Non-genetic Risk
Factors
•

•

•

•
•

Financial problems and homeless

Other mental health co-morbidities
Substance abuse

Suicide Ideation (Mayo Clinic, n.d.)

(Figure 1)

The findings displayed from Knochel et
al., 2017 study showing the protein
levels correlation between controls, SZ,
and BD. Retrieved from
https://login.ezproxy.otterbein.edu/logi
n?url=https://search.ebscohost.com/
log in.aspx?
direct=true&db=pbh&AN=1219
19330&login.asp&site=ehost-

live&scope=site
Text
Text

•
•

•

•
•

Large genome-wide associated
studies (GWAS), have made
advancements in understanding
genic make-up and SZ. SZ is not
determined by just one gene. There
is estimated to be over 100 risk
gene loci. Correlation between
cognitive and gene factors SZ has
also been noted. It is believed the
phenotypes are polygenic. The
strongest correlation lies in
chromosome 22q13.2.

Not all scientists support genetics as
the alone cause of SZ. However, having
an individual genetic predisposition
may be influenced by other factors.
Mothers who have been exposed to
viruses have an increased chance their
child will have SZ.

Viruses can also attack the brain cells,
lay dormant, affect neurotransmitters,
and alter brain cell processes.

•

•

There is a 60 to 80% chance SZ will
be passed on to children, and family
members who do not express the
traits still have

Exposure to lead, such as lead found in
lead paint.
Evidence supporting people who have
the herpes simplex virus and
cytomegalovirus have antibodies that
can cause genes to develop SZ.

A study conducted by Knochel et al.,
2017, researched genomics to
discover protein levels that reflect SZ
and bipolar disorder's
pathophysiology. They also used a
trans-diagnostic approach with MRI
measurements and found differing
protein levels; see figure 1. ApoC also
differed between participants and
showed correlations to cogitative
impairment. Furthermore, ApoC
showed a relationship between
hippocampus volumes and the
severity of impairment. The more
cognitive issues a participant had, the
more considerable changes in Apo
concentrations. Findings showed that
low hippocampal (HC)

Antibodies to toxoplasmosis gondii
have been associated with SZ.

Someone is more likely to develop SZ
in metropolitan areas versus rural
areas..

•

•

•

•

Women in famine during pregnancy
have an increased chance of having a
child with SZ (Cause and Risk Factors
of Schizophrenia, n.d.)

•

•
Image retrieved from: https://www.123rf.com/photo_52545507_photo-of-psychoticwoman-with-schizophrenia-during-treatment.html?vti=mqkdlco09ouubr98fm-1-8
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Nursing Implications

Significance

•
•

a chance their children will have
cognitive and psychiatric issues.

•
•

Those diagnosed with SZ have shown •
notable amounts of cognitive
impairment with insight, judgment,
memory, and concentration. Another
correlation is that premorbid
cognitive issues are related to later
developing psychotic disorders
(Smeland & Andreassen, 2018).

volume equaled increased ApoC.

A study conducted with catechol-Omethyltransferase (COMT) DNA
methylation extracted from the
peripheral blood using a linear
regression analysis showed the
relationship between COMT DNA
methylation and excitement and
depression symptoms of SZ (Nou El
Huda et al., 2018).

Currently, no treatment exists for
cognitive dysfunction for those
with SZ. Cognitive function can be
a predictor of overall life outcomes
in psychotic disorder.

•

Researchers are gaining more
biological insight to discover
treatments. The Psychiatric
Genomics Consortium is gaining
recognition for advancement in
analyzing genetic data. However,
new statistical procedures are
required to discover the missing
genetic links.

•

•

By discovering a single gene
characteristic, it has become
possible to make advancements in
target drugs. The FDR method has
been utilized to reference SZ with
other traits, and when another
trait is recognized to co-exist with
a SZ trait, that information can be
used to prioritize by suggestive
association (Smeland &
Andreassen, 2018).

Apo can be used as biomarkers for
psychomotor speed, executive
functioning, and intelligence,
which can be SZ indicators.

Low volumes in HC can mean more
suffering for those with SZ. More
care measures can be
implemented.
Findings from Knochel et al., 2017,
and GWAS may lead to finding
biological diagnostic tools for SZ
(Knochel et al., 2017).

DNA methylation of COMT in
peripheral blood can be used for
biomarkers for SZ. The event of
hyperfunction of dopamine
suggest the methylation-gene
expression is difficult to obtain
correctness due to methods used
, and demographics, and the
dopamine hypothesis of SZ may
not hold (Nour El Huda et al.,
2018).

•

•

Genomics has been added to the
Scope and Standards of Practice by
the ANA.

The Advanced Practice Nurse
should be prepared for continual up
to date education for genomic and
SZ.
Clinicians need to have a full
understanding of
pharmacogenomics.

Be prepared to educate patients
understandably based on their
culture, knowledgebase, reading
capability, and language.

Present all aspects of genomics with
patients. There are both ethical and
legal issues to consider.
Be able to perform a risk
assessment to relay information to
pharmacists, genetic counselors,
and geneticists (McCormick, 2017)

Conclusion
•

Research is changing rapidly, and
clinicians need to stay on top of new
data to manage their patients' care
properly. There have been many
advancements in genomics related to
SZ, such as phenotypes are
polygenic, DNA methylation of COMT
can lead to biomarkers, and the
correlation with cognitive
impairment and SZ. There is an
ongoing issue with funding for
genomic studies toward mental
health disorders. Mental health
studies are funded less compared to
that of cancer. All three studies
discussed in this project ends with a
cautionary note that the study of
genomic and SZ still require further
investigation. As long as more
extensive research is completed,
there is hope for more quality
outcomes.
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